0.00
price down icon100.00%   -7.02
 
loading
前日終値:
$7.02
開ける:
$0
24時間の取引高:
0
Relative Volume:
0.00
時価総額:
$562.77M
収益:
$414.29M
当期純損益:
$-99.81M
株価収益率:
0.00
EPS:
-1.3348
ネットキャッシュフロー:
$-28.65M
1週間 パフォーマンス:
-100.00%
1か月 パフォーマンス:
-100.00%
6か月 パフォーマンス:
-100.00%
1年 パフォーマンス:
-100.00%
1日の値動き範囲:
Value
$0.00
$0.00
1週間の範囲:
Value
$0.00
$0.00
52週間の値動き範囲:
Value
$0.00
$7.695

Accolade Inc Stock (ACCD) Company Profile

Name
名前
Accolade Inc
Name
セクター
Healthcare (1176)
Name
電話
610-834-2989
Name
住所
660 W. GERMANTOWN PIKE SUITE 500, PLYMOUTH MEETING
Name
職員
2,400
Name
Twitter
Name
次回の収益日
2025-01-13
Name
最新のSEC提出書
Name
ACCD's Discussions on Twitter

ACCD を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Health Information Services icon
ACCD
Accolade Inc
0.00 562.77M 414.29M -99.81M -28.65M -1.3348
Health Information Services icon
VEEV
Veeva Systems Inc
235.07 39.16B 2.75B 714.14M 1.09B 4.33
Health Information Services icon
TEM
Tempus Ai Inc
59.92 11.21B 803.32M -709.10M -212.68M -7.8003
Health Information Services icon
HQY
Healthequity Inc
102.39 8.50B 1.15B 96.70M -161.99M 1.09
Health Information Services icon
DOCS
Doximity Inc
51.14 11.16B 550.17M 201.35M 232.07M 1.00
Health Information Services icon
WAY
Waystar Holding Corp
38.83 6.83B 906.14M -52.62M 89.62M -0.3621

Accolade Inc Stock (ACCD) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-06-28 繰り返されました Needham Buy
2024-02-26 開始されました Leerink Partners Outperform
2024-01-17 再開されました DA Davidson Neutral
2024-01-03 開始されました Barclays Equal Weight
2023-05-24 アップグレード BofA Securities Neutral → Buy
2023-04-12 開始されました Stephens Overweight
2023-03-23 アップグレード Guggenheim Neutral → Buy
2023-02-09 ダウングレード Jefferies Buy → Hold
2023-02-02 開始されました Raymond James Outperform
2022-09-08 再開されました Piper Sandler Overweight
2022-09-07 開始されました Truist Buy
2022-08-12 開始されました DA Davidson Buy
2022-05-02 アップグレード Wells Fargo Underweight → Equal Weight
2022-04-29 ダウングレード BTIG Research Buy → Neutral
2022-04-29 ダウングレード BofA Securities Buy → Neutral
2022-04-29 ダウングレード Credit Suisse Outperform → Neutral
2022-04-29 ダウングレード Morgan Stanley Overweight → Equal-Weight
2022-04-29 ダウングレード SVB Leerink Outperform → Mkt Perform
2022-04-11 開始されました Wells Fargo Underweight
2022-04-07 開始されました Guggenheim Neutral
2022-04-01 再開されました Credit Suisse Outperform
2022-02-11 開始されました Goldman Buy
2021-12-02 開始されました Jefferies Buy
2021-09-30 開始されました Berenberg Buy
2021-09-17 アップグレード Robert W. Baird Neutral → Outperform
2021-05-28 開始されました Robert W. Baird Neutral
2021-05-06 アップグレード SVB Leerink Mkt Perform → Outperform
2021-04-15 開始されました Needham Buy
2021-03-11 再開されました Goldman Buy
2021-01-15 アップグレード Credit Suisse Neutral → Outperform
2021-01-07 開始されました BTIG Research Buy
2020-12-08 開始されました Canaccord Genuity Buy
2020-09-22 開始されました DA Davidson Buy
2020-07-27 開始されました BofA Securities Buy
2020-07-27 開始されました Credit Suisse Neutral
2020-07-27 開始されました Goldman Buy
2020-07-27 開始されました Morgan Stanley Overweight
2020-07-27 開始されました Piper Sandler Overweight
2020-07-27 開始されました Robert W. Baird Outperform
2020-07-27 開始されました SVB Leerink Outperform
すべてを表示

Accolade Inc (ACCD) 最新ニュース

pulisher
May 17, 2025

Analyzing Accolade (NASDAQ:ACCD) & Spree Acquisition Corp. 1 (NYSE:SHAP) - Defense World

May 17, 2025
pulisher
May 14, 2025

Raymond James Financial Inc. Takes $120,000 Position in Accolade, Inc. (NASDAQ:ACCD) - Defense World

May 14, 2025
pulisher
May 10, 2025

Shareholder Rights Advocates at Levi & Korsinsky Investigate Accolade, Inc. (ACCD) Regarding Possible Securities Fraud Violations - ACCESS Newswire

May 10, 2025
pulisher
May 03, 2025

Seth Rollins Reveals The One Accolade He Wants That Has Escaped Him In WWE Career - Wrestling Inc.

May 03, 2025
pulisher
May 02, 2025

Accolade Wines to cut brands following Vinarchy launch - Yahoo

May 02, 2025
pulisher
Apr 30, 2025

Vinarchy unveiled as Pernod, Accolade close wine deal - Yahoo

Apr 30, 2025
pulisher
Apr 30, 2025

Vinarchy: A New Global Wine Company - Business Wire

Apr 30, 2025
pulisher
Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025
pulisher
Apr 26, 2025

Accolade, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Accolade (ACCD) - ACCESS Newswire

Apr 26, 2025
pulisher
Apr 25, 2025

Adventus Singapore Pte. Ltd. bags accolade at SBR National Business Awards 2025 - Singapore Business Review

Apr 25, 2025
pulisher
Apr 22, 2025

Accolade president Robert Cavanaugh sells shares worth $3,857 - MSN

Apr 22, 2025
pulisher
Apr 11, 2025

Digital health startup Transcarent takes Accolade private in $621 million deal - MSN

Apr 11, 2025
pulisher
Apr 10, 2025

MedEthix Inc earns two accolades at Healthcare Asia Pharma Awards 2025 - Healthcare Asia Magazine

Apr 10, 2025
pulisher
Apr 09, 2025

Transcarent finalizes merger with Accolade - MobiHealthNews

Apr 09, 2025
pulisher
Apr 08, 2025

Telehealth startup completes $621 million acquisition of Seattle's Accolade - The Business Journals

Apr 08, 2025
pulisher
Apr 08, 2025

Accolade completes merger with Transcarent, shifts control By Investing.com - Investing.com Canada

Apr 08, 2025
pulisher
Apr 08, 2025

Accolade completes merger with Transcarent, shifts control - Investing.com

Apr 08, 2025
pulisher
Apr 08, 2025

Transcarent Completes Merger With Accolade - Business Wire

Apr 08, 2025
pulisher
Apr 04, 2025

AcCOLADE president Robert Cavanaugh sells $3,845 in stock By Investing.com - Investing.com Canada

Apr 04, 2025
pulisher
Apr 03, 2025

Accolade EVP general counsel sells $2,642 in stock - Investing.com Australia

Apr 03, 2025
pulisher
Apr 03, 2025

Accolade EVP general counsel sells $2,642 in stock By Investing.com - Investing.com South Africa

Apr 03, 2025
pulisher
Apr 03, 2025

AcCOLADE president Robert Cavanaugh sells $3,845 in stock - Investing.com

Apr 03, 2025
pulisher
Apr 03, 2025

Accolade’s CFO Stephen Barnes sells shares worth $3,013 By Investing.com - Investing.com South Africa

Apr 03, 2025
pulisher
Apr 03, 2025

Accolade’s CFO Stephen Barnes sells shares worth $3,013 - Investing.com

Apr 03, 2025
pulisher
Mar 30, 2025

Levi & Korsinsky Investigates Possible Securities Fraud Violations by Accolade, Inc. (ACCD) - ACCESS Newswire

Mar 30, 2025
pulisher
Mar 29, 2025

Is Accolade Inc. (NASDAQ:ACCD) the Best Performing Stock So Far In 2025? - MSN

Mar 29, 2025
pulisher
Mar 28, 2025

Accolade shareholders approve merger with Transcarent By Investing.com - Investing.com India

Mar 28, 2025
pulisher
Mar 27, 2025

Accolade Stockholders Approve Merger with Transcarent - TipRanks

Mar 27, 2025
pulisher
Mar 27, 2025

Accolade Shareholders Greenlight Merger With Transcarent - MarketScreener

Mar 27, 2025
pulisher
Mar 27, 2025

Accolade shareholders approve merger with Transcarent - Investing.com

Mar 27, 2025
pulisher
Mar 27, 2025

Accolade Stockholders Approve Merger Between Accolade and Transcarent - GlobeNewswire

Mar 27, 2025
pulisher
Mar 21, 2025

GLAZER CAPITAL, LLC Acquires Significant Stake in Accolade Inc - GuruFocus

Mar 21, 2025
pulisher
Mar 19, 2025

Accolade president Robert Cavanaugh sells $1,264 in stock By Investing.com - Investing.com Australia

Mar 19, 2025
pulisher
Mar 19, 2025

Accolade CFO Stephen H. Barnes sells $991 worth of stock By Investing.com - Investing.com Australia

Mar 19, 2025
pulisher
Mar 19, 2025

Accolade CEO Rajeev Singh sells $2,018 in stock By Investing.com - Investing.com Australia

Mar 19, 2025
pulisher
Mar 19, 2025

Accolade president Robert Cavanaugh sells $1,264 in stock - Investing.com India

Mar 19, 2025
pulisher
Mar 19, 2025

Accolade CEO Rajeev Singh sells $2,018 in stock - Investing.com India

Mar 19, 2025
pulisher
Mar 19, 2025

Accolade CFO Stephen H. Barnes sells $991 worth of stock - Investing.com

Mar 19, 2025

Accolade Inc (ACCD) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
health_information_services PHR
$24.41
price down icon 0.24%
$11.32
price up icon 1.07%
$23.25
price up icon 0.76%
$23.64
price down icon 0.84%
$23.55
price down icon 1.10%
health_information_services WAY
$39.01
price down icon 0.94%
大文字化:     |  ボリューム (24 時間):